Stay ahead of the curve

MoCRA gave FDA recall authority over cosmetics for the first time in 80+ years. Most brands adapted to registration — fewer adapted their label verification.

Some MLR review time is unavoidable. A significant portion isn't review time at all — it's version confusion, and that part is avoidable.

Marketing blames procurement. Supply chain blames suppliers. The real driver of FMCG launch delays is a labeling error caught at the proof stage.

Most 21 CFR Part 11 findings aren't deliberate non-compliance — they're specific, recurring assumptions about the regulation that don't hold up at inspection.

Why treating packaging artwork as structured data, not a static file, is the shift regulated industries need to make in version control and verification.

Three reviewers approved a campaign. None of them saw the same version. Why MLR platforms haven't solved the version confusion problem in promotional review.

A routine IFU revision, compared against the wrong baseline, missed a single character. Why delta reviews miss the changes that matter most.

Regulators are drawing a clear line between deterministic and generative AI in GxP processes. What does that distinction entail for pharma teams?

FMCG recalls aren't random — the data shows structural patterns behind allergen labeling failures, and where most brands' review process is still exposed.

Three languages, three clean sign-offs, one allergen highlighted wrong. Why FMCG label review misses errors that only appear when versions are compared.

Why regulatory inspection preparation takes days for most pharma QA teams — and how a documented, audit-trail-driven review process turns it into hours.

Discover the critical labeling changes under EU MDR that medical device teams often overlook, ensuring compliance and avoiding costly audit findings.

Discover why most pharmaceutical labeling errors occur late in the process and how automated checks can enhance accuracy before products reach patients.

Discover five critical warning signs that your pharma review process may be increasing risk instead of mitigating it, and learn how to improve compliance.

No implementation project. Content Compare onboarding covers IQ, live training, and Hypercare support — browser-based and built for regulated teams from day one

Evaluating InformaIT alternatives? An honest comparison of Content Compare, GlobalVision Verify, and Schlafender Hase TVT — and what to ask before you decide.

Explore how last-minute changes in pharmaceutical labeling can lead to costly errors and the importance of automated comparisons in ensuring accuracy.

From false positives to inflexible licensing, here are the real reasons regulated industry teams make the switch to Content Compare.

Ensure your device labeling complies with EU MDR requirements before the May 2026 deadline to avoid costly non-conformities and market delays.

Discover how integrating compliance into medical device marketing strategies can enhance speed and efficiency, turning it into a competitive advantage.

Discover why version control, not reviewer bandwidth, is the real bottleneck in MLR reviews and how re-engineering processes can dramatically improve timelines.

InformaIT earns ISO 27001 certification, emphasizing robust information security and compliance for regulated industries.

Discover the truth behind common myths about proofreading software and learn how modern tools enhance accuracy, speed, and compliance in pharma labeling.

ISPE's new guide on digital validation offers best practices for transitioning from paper-based systems, emphasizing governance and integrity in life sciences.

InformaIT integrates with Veeva Vault PromoMats to streamline pharmaceutical marketing compliance, accelerating approvals and enhancing accuracy.

Improve efficiency in regulatory reviews by automating tasks, centralizing document management, and ensuring compliance to meet deadlines and reduce errors.

InformaIT partners with Veeva Systems to enhance compliance and efficiency in life sciences through streamlined content review and approval processes.

Discover how InformaIT is revolutionizing regulated industries with advanced automation, precision, and compliance, enabling regulated businesses to thrive.

Discover how automated quality control enables businesses in regulated industries to scale efficiently, maintain compliance, and ensure high quality standards.

AI has clear potential in regulated industries, but regulatory teams still need traceability, validation and evidence-based proofing.

Discover how automation is revolutionizing quality assurance, enhancing accuracy, compliance, and efficiency in regulated industries like pharmaceuticals.

Avoid common content approval errors in regulated industries with our expert tips and automated solutions for compliance, accuracy, and efficiency.

Meet Mathias Kristoffersson, InformaIT's new CTO, bringing over 20 years of software engineering experience.

Discover the highlights of ESKOWorld 2024, showcasing innovative solutions in content management and automated proofreading.

We attended the 2024 ISPE Europe Annual Conference, where we discussed the latest innovations and shared challenges in the pharmaceutical industry.

We are welcoming our newest team member, Andy Josefsson, to InformaIT. Read more here on what he will contribute to the organization.

InformaIT is pleased to announce the appointment of Jimmy Bäckström, who is taking over as CEO, a role previously held by Mats Svensson.